Psychedelics FDA publishes first draft guidance document for psychedelics research It aims to highlight relevant considerations for researchers investigating the therapeutic value of psychedelics Rowan DunneJune 23, 2023
Health and Safety FDA to reject medical device applications without cyberattack protection plans As many as 40 per cent of end-of-life devices have no protection at all against cyberattacks Joseph MortonMarch 31, 2023
Technology Inspira Technologies seeks FDA approval for cardiopulmonary device The ALICE incorporates several of Inspira's features and capabilities into one handy device Joseph MortonDecember 20, 2022
Sleep Inspire Medical Systems recruits top tier investor relations talent Yagci brings over 15 years experience as an institutional investor in medical devices and healthcare services to the table. Joseph MortonAugust 22, 2022
Business MediPharm Labs to enter US pharmaceutical market via FDA drug registration If approved, it could advance the firm's goal of becoming a dominant supplier of cannabinoid pharmaceutical ingredients Natalia Buendia CalvilloFebruary 23, 2022
Cannabis Delta-8 THC better harm-reduction tool than popular delta-9 THC, study suggests In spite of warnings from major agencies on the dangers of delta-8 THC, researchers say it has therapeutic potential Natalia Buendia CalvilloNovember 25, 2021
News US DEA set to authorize potent pot production for research With only one approved US university supplying low-quality cannabis for decades, the DEA says it will finally open up licensing Jared GnamMay 18, 2021
News MindMed stock surges on Nasdaq listing approval After its stock jumped 66%, MindMed now rivals Compass Pathways as the world's most valuable psychedelic company Jared GnamApril 23, 2021
Industry update Low-THC weed led to poor results in major PTSD study US researchers seek DEA to permit potent pot production after long-awaited FDA-backed study shows weak weed ineffective at treating PTSD Jared GnamMarch 30, 2021
Industry update Charlotte’s Web bounces back in Q4 American CBD market leader reports 2020 sales of US$95.2M and positive results for a third-party liver toxicity study Jared GnamMarch 25, 2021